Real-time enrollment status for this hypertension clinical trial
Current Status
Recruiting
Checked: September 5, 2026 at 3:12 PM UTC
| NCT Number | NCT07758634 |
| Recruiting Status | Recruiting |
| Condition | Hypertension |
| Phase | PHASE1 |
| Target Enrollment | 69 participants |
| Active Locations | 1 sites in the US |
| Sponsor | CRISPR Therapeutics AG |
| Last Updated on CT.gov | August 11, 2026 (3 weeks ago) |
As of September 5, 2026: Clinical trial NCT07758634 is currently recruiting participants. This phase1 study for hypertension is actively seeking new participants at 1 location across the United States. The study is sponsored by CRISPR Therapeutics AG. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07758634 is actively recruiting participants as of September 5, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07758634 was last updated 3 weeks ago (August 11, 2026). HelloStudys verifies this status automatically.